Home > Healthcare > Analytical Instruments > Molecular Analysis > Tangential Flow Filtration Market
By product type, the tangential flow filtration market is classified into systems, membrane filters, and accessories. The systems segment accounted for 52% of the market share in 2022. Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. For instance, according to the International Diabetes Federation report, in 2021, approximately 537 million adults (20-79 years) are living with diabetes. As the global burden of chronic illnesses rises, there is a growing demand for advanced biopharmaceutical products and therapies to effectively address these health challenges.
Based on technology, the tangential flow filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other technologies. The microfiltration segment accounted for 45.7% of the market share in 2022. The integration of microfiltration in TFF systems allows effective clarification of solutions and separation of particulate matter, thereby minimizing clogging and ensuring smooth filtration processes. Also, microfiltration's gentle filtration mechanism preserves the integrity of sensitive biomolecules during the purification process, leading to higher product yields and minimizing product loss.
Based on application, the tangential flow filtration market is segmented into protein purification, vaccine and viral vectors, antibody purification, raw material filtration, and other applications. The protein purification segment is projected to witness considerable development of 11.5% by 2032. Increasing complexity of biopharmaceutical products and the rising demand for novel protein-based therapeutics is expected to supplement the segmental evolution. The integration of advanced automation features in TFF systems streamlines the filtration process by lowering the need for manual intervention and minimizing the chance of human error.
Based on end-use, the tangential flow filtration market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic institutes & research laboratories. The pharmaceutical & biotechnology companies segment is projected to witness considerable growth of 11.8% over the analysis timeframe. Moreover, increasing investment in research and development activities by biopharmaceutical companies to discover new therapies and treatments.
North America tangential flow filtration market accounted for 44.3% industry share in 2022. The presence of numerous prominent pharmaceutical and biotechnology companies that are actively engaged in developing innovative biologics and advanced therapies in the region. Also, presence of well-established TFF technology providers, along with the increasing adoption of advanced technologies.